Treatment completion, treatment compliance and outcomes of old and very old patients treated by dose adapted stereotactic ablative radiotherapy (SABR) for T1-T3N0M0 non-small cell lung cancer
- 9 November 2018
- journal article
- research article
- Published by Elsevier in Journal of Geriatric Oncology
- Vol. 10 (3) , 442-448
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Stereotactic body radiation therapy versus no treatment for early stage non–small cell lung cancer in medically inoperable elderly patients: A National Cancer Data Base analysisCancer, 2015
- Outcomes after Stereotactic Body Radiotherapy versus Limited Resection in Older Patients with Early-Stage Lung CancerJournal of Thoracic Oncology, 2015
- Guideline-concordant lung cancer care and associated health outcomes among elderly patients in the United StatesJournal of Geriatric Oncology, 2015
- Lobectomy, Sublobar Resection, and Stereotactic Ablative Radiotherapy for Early-Stage Non–Small Cell Lung Cancers in the ElderlyJAMA Surgery, 2014
- Stereotactic body radiotherapy for very elderly patients (age, greater than or equal to 85 years) with stage I non-small cell lung cancerRadiation Oncology, 2014
- Stereotactic Body Radiation Therapy in Octogenarians With Stage I Lung CancerClinical Lung Cancer, 2014
- Stereotactic Body Radiotherapy in Patients With Stage I Non–Small-Cell Lung Cancer Aged 75 Years and Older: Retrospective Results From a Multicenter ConsortiumClinical Lung Cancer, 2013
- Stereotactic Ablative Body Radiation Therapy for Octogenarians With Non-Small Cell Lung CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2013
- Stereotactic radiation therapy: changing treatment paradigms for stage I nonsmall cell lung cancerCurrent Opinion in Oncology, 2011
- Impact of Introducing Stereotactic Lung Radiotherapy for Elderly Patients With Stage I Non–Small-Cell Lung Cancer: A Population-Based Time-Trend AnalysisJournal of Clinical Oncology, 2010